Stigma, discrimination-related events, and determinants among adult people living with systemic lupus erythematosus (SLE): Systematic review and indicator-level meta-analysis [0.03%]
狼疮患者的污名化和歧视事件及危险因素：系统评价及指标水平的荟萃分析
Hebatullah M Abdulazeem,Syrine Bellakhal,Rym Abida et al.
Hebatullah M Abdulazeem et al.
BackgroundSystemic lupus erythematosus (SLE) is a complex autoimmune disease with 0.4 million new cases diagnosed annually. With its wide variety of visible and invisible manifestations, people living with SLE report being exposed to stigma...
Network meta-analysis of triple immunosuppressive therapies and standard of care for induction of remission of active lupus nephritis [0.03%]
三联免疫抑制疗法诱导活动性狼疮肾炎完全缓解的网状Meta分析
Gabriel Contreras,Vinodh Mechery,Sanjana Kota et al.
Gabriel Contreras et al.
BackgroundIn patients with active lupus nephritis (LN), 8 different triple immunosuppressive therapies have been compared to the standard of care (SOC) of double immunosuppressive therapy in 12 induction randomized clinical trials (RCTs). T...
CircSMURF2 alleviates cell apoptosis by binding DIABLO promote ubiquitination and its expression level and clinical significance in lupus nephritis [0.03%]
Circular RNA Circsmurf2通过结合Diablo促进其泛素化降解来抑制细胞凋亡及其在狼疮性肾炎中的表达水平及临床意义
Xin Yuan,Lushan Xiao,Qin Huang et al.
Xin Yuan et al.
BackgroundLupus nephritis (LN) is an autoimmune disease that affects kidneys and is considered one of the most prevalent complications of systemic lupus erythematosus (SLE). We screened differentially expressed circRNAs through circRNA sequ...
Validation and prognostic utility of SLERPI in a single-centre retrospective Central European cohort [0.03%]
SLERPI在单中心中欧地区回顾性队列中的验证和预后价值
Andrea Zoli,Seda Nur Aydogdu,Danae-Mona Nöthling et al.
Andrea Zoli et al.
ObjectivesTo evaluate the diagnostic performance of the SLE Risk Probability Index (SLERPI) in a European cohort and explore its potential prognostic utility for early flare risk stratification.MethodsThis retrospective study included 280 p...
Clinical phenotypes and disease outcomes of patients with systemic lupus erythematosus meeting indication for primary aldosteronism testing [0.03%]
系统性红斑狼疮患者原发性醛固酮增多症检查的临床表型及预后分布
Matthew Wong,Muhammad Akram,Joanna R Kent et al.
Matthew Wong et al.
BackgroundHypertension is prevalent and contributes significantly to cardiovascular risk in patients with systemic lupus erythematosus (SLE). Primary aldosteronism (PA), the most common endocrine cause of hypertension, confers higher cardio...
Persistence of antimalarial therapy and its effect on mortality in systemic lupus erythematosus: A population-based longitudinal multistate study [0.03%]
抗疟药治疗的持续性及其对系统性红斑狼疮患者死亡率的影响：一项基于人口的纵向多状态研究
Kai Zhao,Bocheng Jing,Bingfan Liu et al.
Kai Zhao et al.
ObjectiveExamine patients' Antimalarials (AM) use history and identify determinants of transitions among AM persistence, discontinuation, and death in a population-based incident cohort of Systemic Lupus Erythematosus (SLE) patients receivi...
Impact of parenting on patient-reported outcomes in female patients with systemic lupus erythematosus: A cross-sectional study of the LUNA registry [0.03%]
父母育儿方式对狼疮幸存者患者报告结果的影响——LUNA登记系统横断面研究分析
Dai Kishida,Takanori Ichikawa,Yasuhiro Shimojima et al.
Dai Kishida et al.
ObjectivesAlthough pregnancy and childbirth are critical for patients with systemic lupus erythematosus (SLE), patients who continue to parent their children during treatment have received little attention. In this study, we aimed to invest...
Inaugural complete heart block in anti-SSA negative systemic lupus erythematosus: the diagnostic role of anti-PM-Scl 100 antibodies [0.03%]
抗SSA阴性的系统性红斑狼疮出现完全性房室传导阻滞的首诊病例及抗PM-Scl 100抗体的诊断意义
Nadia Dammene Debbih,Leila Laouar,Nassima Dekdouk et al.
Nadia Dammene Debbih et al.
IntroductionComplete heart block (CHB) is an exceptionally rare manifestation of adult systemic lupus erythematosus (SLE), typically occurring in less than 1% of patients. While classically associated with anti-SSA/Ro antibodies, we report ...
Serum C-reactive protein levels can predict organ damage in patients with SLE with the lupus low disease activity state [0.03%]
CRP水平可以预测LLDAS下SLE患者的器官损害风险
Tomoya Nakajima,Akira Onishi,Mirei Shirakashi et al.
Tomoya Nakajima et al.
ObjectivesThe importance of low detectable C-reactive protein (CRP) levels in patients with systemic lupus erythematosus (SLE) remains unclear. This study aimed to examine the association between CRP levels and damage accrual in SLE patient...
Two cases of therapy-refractory chilblain lupus erythematosus successfully treated with deucravacitinib [0.03%]
两例对传统治疗无效的冻疮样狼疮使用德鲁伐单抗注射液成功治疗的病例报告
Robin Springer,Andrew Moufarrej,Bernhard Homey et al.
Robin Springer et al.
Chilblain lupus erythematosus is a rare skin manifestation of lupus erythematosus (LE), which has proven particularly difficult to treat and therefore often presents a great challenge for patients and physicians. We treated two patients wit...